Radiologic and clinical predictors of malignancy in the follicular lesion of undetermined significance of the thyroid

Endocrine Pathology

Volumn 24, Issue 2, 2013, Pages 62-68

  Carr, Ryan ^a   Ustun, Berrin ^a   Chhieng, David ^a   Schofield, Kevin ^a   Theoharis, Constantine ^a   Hammers, Lynwood ^a   Adeniran, Adebowale J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fine needle aspiration; Follicular lesion of undetermined significance; Indeterminate; Predictors of malignancy; Thyroid

Indexed keywords

B RAF KINASE;

ARTICLE; BRAF GENE; CALCIFICATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTODIAGNOSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FAMILY HISTORY; FEMALE; FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; SYNDROME DELINEATION; THYROID CALCINOSIS; THYROID CANCER; THYROID DISEASE; TISSUE CHARACTERIZATION; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; CONNECTICUT; FEMALE; HUMANS; MALE; MUTATION; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84878241948     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-013-9240-4     Document Type: Article

References (35)

1. Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid. Acta Cytol 31:587-590, 1987.
2. Faquin WC, Baloch ZW. Fine-Needle Aspiration of Follicular Patterned Lesions of the Thyroid: Diagnosis, Management, and Follow-Up According to National Cancer Institute (NCI) Recommendations. Diagn Cytopathol 38:731-739, 2010.
3. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer - Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214, 2009.
4. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid 19:1159-1165, 2009.
5. Broome JT, Solorzano CC. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: Evaluation of the Bethesda System for Reporting Thyroid Cytopathology. Surgery 150:1234-1241, 2011.
6. Teixeira GV, Chikota H, Teixeira T, et al. Incidence of Malignancy in Thyroid Nodules Determined to be Follicular Lesions of Undetermined Significance on Fine-Needle Aspiration. World J Surg 68:1336-1338, 2011.
7. Cross PA, Poller D. The Bethesda thyroid terminology and progress towards international agreement on thyroid FNA cytology reporting. Cytopathology 21:71-74, 2010.
8. Clark DP, Faquin WC. Thyroid cytopathology. New York: Springer, 2005.
9. Cibas ES, Ducatman BS. Cytology: diagnostic principles and clinical correlates. New York: Saunders, 2009.
10. Faquin WC. Diagnosis and Reporting of Follicular-Patterned Thyroid Lesions by Fine Needle Aspiration. Head and Neck Pathol 3:82-85, 2009.
11. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143-150, 2002.
12. Oertel YC, Burman K, Boyle L, et al. Integrating fine-needle aspiration into a daily practice involving thyroid disorders: The Washington Hospital Center Approach. Diagn Cytopathol 120:120-122, 2007.
13. Layfield LJ, Morton MJ, Cramer HM, et al. Implications of the proposed thyroid fine-needle aspiration category of "follicular lesion of undetermined significance": a five-year multi-institutional analysis. Diagn Cytopathol 37:710-714, 2009.
14. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a summation. Cytojournal 5:6, 2008.
15. Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306-315, 2007.
16. Deandrea M, Ragazzoni F, Motta M, et al. Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 20:1077-1083, 2010.
17. Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 19;1215-1223, 2009.
18. Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 134:450-456, 2010.
19. Layfield LJ, Cibas ES, Baloch ZW, et al. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium. Cytopathology 21:75-85, 2010.
20. Adeniran AJ, Hui P, Chhieng DC, et al. BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Specimens Enhances the Predictability of Malignancy in Thyroid Follicular Lesions of Undetermined Significance. Acta Cytol 55:570-575, 2011.
21. Dutta S, Thaha MA, Smith DM. Do sonographic and cytological features predict malignancy in cytologically indeterminate thyroid nodules? Ann R Coll Surg Engl 93:361-364, 2011.
22. Tyler DS, Winchester DJ, Caraway NP, et al. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 116:1054-1060, 1994.
23. Banks ND, Kowalski J, Tsai HL, et al. A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 18:933-941, 2008.
24. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 69:44-49, 1994.
25. Horne MJ, Chhieng DC, Theoharis C, et al. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification. Diagn Cytopathol. 40:410-415, 2012
26. Sahin M, Gursoy A, Tutuncu NB, Guvener DN. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin Endocrinol 65:514-518, 2006.
27. Miller B, Burkey S, Lindberg G, et al. Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 188:459-462, 2004.
28. Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 136:334-337, 2001.
29. Filicori F, Keutgen XM, Buitrago D, et al. Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis. Surgery 150:1085-1091, 2011.
30. Pelizzo MR, Boschin IM, Barollo S, et al. BARF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Clin Chem Lab Med 49:325-329, 2011.
31. Haugen BR, Woodmansee WW, McDermott MT. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol 56:281-290, 2002.
32. Rabaglia JL, Kabbani W, Wallace L, et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 148:1267-1272, 2010.
33. Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer 117:298-304, 2009.
34. Prasad ML, Pellegata NS, Huang Y, et al. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol. 18:48-57, 2005.
35. Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME1 combined with CK19 immunostaining. Mod Pathol. 19:1631-1637, 2006.